Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation

Cell

Volumn 79, Issue 7, 1994, Pages 1137-1146

  Mannick, Joan B ^a,b   Asano, Koichiro ^b   Izumi, Kenneth ^a,b   Kieff, Elliott ^a,b   Stamler, Jonathan S ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; COMPLEMENTARY DNA; CYCLIC GMP; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; THIOL DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL DEATH; CONTROLLED STUDY; DIAGNOSIS; DNA SEQUENCE; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALIA; ECTROMELIA VIRUS; HERPES; HUMAN HERPESVIRUS 4; MURINAE; SIMPLEXVIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0028658374     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(94)90005-1     Document Type: Article

References (78)

1. Redox regulation of fos and jun DNA-binding activity in vitro
2. Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway
3. Early events in Epstein-Barr virus infection of human B lymphocytes
4. Constitutive and inducible nitric oxide synthase gene expression activity and regulation in human lung epithelial cells
5. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes
6. Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide
7. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
8. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding
9. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells
10. Human alveolar and peritoneal macrophages mediate fungistasis independently of l-arginine oxidation to nitrite or nitrate
11. Both Epstein-Barr virus (EBV)-encoded trans-acting factors EB1 and EB2 are required to activate transcription from an EBV early promoter
12. Signalling by non-receptor surface-mediated surface active biomolecules
13. Evidence for antiviral effect of nitric oxide
14. Activation of latent EBV via anti-IgG-triggered second messenger pathways in the Burkitt's lymphoma cell line Akata
15. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates
16. +2
17. Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos
18. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1
19. Inhibition of interleukin-2 production in the human T cell line JURKAT by nonpolar maleimides
20. Tyrosine phosphorylation in T cells is regulated by phosphatase activity studies with phenylarsine oxide
21. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways
22. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes
23. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding
24. Macrophage production of nitrogen oxides in host defence against microorganisms
25. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis
26. Tetrahydrobiopterin synthesis
27. g-methylarginine
28. The bZIP transactivator of Epstein-Barr virus BZLF1 functionally and physically interacts with the p65 subunit of NF-kappa B
29. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity
30. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
31. Effect of arginine-deficient media on the herpes-type virus associated with cultured Burkitt tumor cells
32. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma
33. Synthesis of nitric oxide from l-arginine a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity
34. Macrophage cytotoxicity role for l-arginine deiminase and imino nitrogen oxidation to nitrite
35. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
36. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of l-arginine
37. Bcl-2 inhibition of neural death decreased generation of reactive oxygen species
38. Nitric oxide an inhibitor of lipid oxidation by lipoxygenase cyclooxygenase and hemoglobin
39. Sulfhydryl oxidation down-regulates T-cell signaling and inhibits tyrosine phosphorylation of phospholipase C gamma 1
40. Inhibition of viral replication by interferongamma-induced nitric oxide synthase
41. Cloned murine T lymphocytes synthesize a molecule with the biological characteristics of nitric oxide
42. Production of monoclonal antibody to a late intracellular Epstein-Barr virus-induced antigen
43. Nitric oxide synthase in human and rat lung immunocytochemical and histochemical localization
44. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B
45. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages
46. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds
47. Nitric oxide signaling a possible role for G proteins
48. The leucine zipper a hypothetical structure common to a new class of DNA-binding proteins
49. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
50. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing
51. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation
52. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional EBV-genome-negative African Burkitt's lymphoma
53. Mechanism of covalent modification of glyceraldehyde 3-phosphate dehydrogenase at its active site thiol by nitric oxide peroxynitrite and related nitrosating agents
54. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation
55. Nitric oxide physiology pathophysiology and pharmacology
56. Nitric oxide as a secretory product of mammalian cells
57. Role of nitric oxide synthesis in macrophage antimicrobial activity
58. Regulation of the biosynthesis of nitric oxide
59. Nitric oxide synthases roles tolls and controls
60. Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent
61. Peroxynitrite oxidation of sulfhydryls
62. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency
63. Phenylarsine oxide (PAO) blocks antigen receptor-induced calcium response and tyrosine phosphorylation of a distinct group of proteins
64. Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis
65. Nitric oxide synthase induces macrophage death by apoptosis
66. A role for oxygen radicals as second messengers
67. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1
68. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures
69. S-nitrosothiols and bioregulatory interactions of nitrogen oxides with thiol groups
70. Redox signaling nitrosylation and related target interactions of nitric oxide
71. Biochemistry of nitric oxide and its redox-activated forms
72. S-nitrosylation of proteins with nitric oxide synthesis and characterization of biologically active compounds
73. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines
74. Trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment
75. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells
76. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro
77. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia
78. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity